Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00119626 | Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke | PHASE3 | COMPLETED | 1,700 | — | — | Jun 1, 2003 | Feb 1, 2005 | Nov 15, 2010 | 2 | Sweden, United Kingdom |
| NCT00061022 | Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke | PHASE3 | COMPLETED | 3,200 | — | — | May 1, 2003 | Sep 1, 2006 | Nov 15, 2010 | 256 | United States, Argentina +28 |
| Name | Type | Description |
|---|---|---|
| NXY-059 | DRUG | - |
Inclusion Criteria: * Males and females * Acute ischemic stroke with limb weakness, onset of symptoms within 6 hours * Full functional independence prior to the present stroke Exclusion Criteria: * Unconsciousness * Subjects who are unlikely to complete the infusion of investigational product and...